3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
8
Rhabdoid Tumor
7
Osteosarcoma
7
Neuroblastoma
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Sarcoma
6
Rhabdomyosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Histiocytosis, Langerhans-Cell
6
Glioma
6
Ependymoma
6
Central Nervous System Neoplasms
5
Sarcoma, Ewing
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Ovarian Neoplasms
2
Neuroendocrine Tumors
2
Nasopharyngeal Carcinoma
2
Immunoglobulin Light-chain Amyloidosis
2
Endometrial Neoplasms
2
Desmoid Tumors
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Xanthogranuloma, Juvenile
1
Thyroid Cancer, Papillary
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Sarcoma, Synovial
1
Interventions
pembrolizumab
44
Carboplatin
35
Paclitaxel
27
Specimen Handling
18
Cyclophosphamide
16
Capecitabine
16
Magnetic Resonance Spectroscopy
14
sacituzumab govitecan
13
Gemcitabine
13
Taxes
12
Biopsy
12
130-nm albumin-bound paclitaxel
11
Albumin-Bound Paclitaxel
9
olaparib
8
Doxorubicin
8
Nivolumab
7
fludarabine
6
Cisplatin
6
eribulin
5
atezolizumab
5
Radiotherapy
5
Docetaxel
5
durvalumab
4
Fulvestrant
4
Epirubicin
4
Bevacizumab
4
veliparib
3
famitinib
3
abemaciclib
3
Vinorelbine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Phantoms, Imaging
×
90 days
×
Clear all
No trials found.